Neurocrine Biosciences | NBIX - 債務の支払利息





債務の支払利息 変化する 日付
AbbVie USD 688M 58M 2026-09
Acadia Pharmaceuticals USD 0 4.12M 2024-09
Agios Pharmaceuticals USD 1.06B 44.38M 2026-09
ALKERMES USD 27.55M 1.63M 2026-09
Alnylam Pharmaceuticals USD -84.37M 166.42M 2026-09
Amgen USD 653M 94.99B 2026-09
Biogen USD 72.6M 12.6M 2025-06
BioMarin Pharmaceutical USD 55.63M 7.67M 2026-09
Cytokinetics USD 38.48M 3.65M 2026-09
Enanta Pharmaceuticals USD 1.96M 620K 2024-12
Exelixis USD 23.4M 3.9M 2023-09
Gilead Sciences USD 269M 22M 2026-09
Halozyme Therapeutics USD 6.04M 457K 2026-09
Incyte USD 605K 23K 2026-09
Ionis Pharmaceuticals USD 18M 1000K 2026-06
Nektar Therapeutics USD 7.94M 1.83M 2026-03
Neurocrine Biosciences USD 300K 2.6M 2026-09
Pfizer USD 662M 5M 2026-09
Prothena USD 283.52M 19.06M 2026-09
Regeneron Pharmaceuticals USD 11M 1.9M 2026-06
Repligen USD 5.71M 49K 2026-09
Rigel Pharmaceuticals USD 2.06M 31K 2024-09
Sarepta Therapeutics USD 21.51M 205K 2026-06
Teva Pharmaceutical Industries USD 414M 219M 2026-09
Ultragenyx Pharmaceutical USD 20M 2M 2026-09
Vertex Pharmaceuticals USD 36M 32.7M 2026-09